SC
IBB icon

Syon Capital’s iShares Biotechnology ETF IBB Stock Holding History

Syon Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$273K Buy
1,434
+3
+0.2% +$516 0.01% 833
2026
Q1 		$242K Buy
1,431
+228
+19% +$39K 0.01% 817
2025
Q4 		$203K Buy
+1,203
New +$195K 0.01% 867
2025
Q2 		– Sell
-4,119
Closed -$527K – 752
2025
Q1 		$527K Sell
4,119
-3,623
-47% -$491K 0.04% 299
2024
Q4 		$1.02M Buy
+7,742
New +$1.09M 0.09% 157

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Syon Capital's IBB Position: Q2 2026 in Review

Syon Capital increased its iShares Biotechnology ETF (IBB) stake by 0.21% in Q2 2026, buying an estimated $516 and bringing the position to 1,434 shares worth $273K. The position accounts for 0.01% of the portfolio, ranked #833.

Syon Capital first reported a position in IBB in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.02M in Q4 2024. 958 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Syon Capital held 1,434 shares of iShares Biotechnology ETF worth $273K as of Q2 2026.
  • Syon Capital bought 3 iShares Biotechnology ETF shares in Q2 2026, an estimated $516.
  • iShares Biotechnology ETF made up 0.01% of Syon Capital's portfolio in Q2 2026, its #833 holding.
  • Syon Capital first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 5 quarters since.
  • Syon Capital's iShares Biotechnology ETF position peaked at $1.02M in Q4 2024.
  • 958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.